A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People - Trial NCT06367426
Access comprehensive clinical trial information for NCT06367426 through Pure Global AI's free database. This Phase 1 trial is sponsored by Pharmacobio and is currently Recruiting. The study focuses on Alzheimer Disease. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Pharmacobio
Timeline & Enrollment
Phase 1
Apr 01, 2024
May 01, 2025
Primary Outcome
Assessment of safety and tolerability of DDN-A-0101 by monitoring vital signs,Assessment of safety and tolerability of DDN-A-0101 by monitoring vital signs,Assessment of safety and tolerability of DDN-A-0101 by monitoring vital signs,Assessment of safety and tolerability of DDN-A-0101 by monitoring ECG,Assessment of safety and tolerability of DDN-A-0101 by C-SSRS measurement,Assessment of safety and tolerability of DDN-A-0101 by laboratory safety tests,Assessment of safety and tolerability of DDN-A-0101 by laboratory safety tests,Assessment of safety and tolerability of DDN-A-0101 by laboratory safety tests,Assessment of pharmacokinetics of Quercitrin, an indicator of of DDN-A-0101 in plasma,Assessment of pharmacokinetics of Quercitrin in plasma,Assessment of pharmacokinetics of Quercitrin in plasma,Assessment of pharmacokinetics of Quercitrin in plasma,Assessment of pharmacokinetics of Quercitrin in plasma,Assessment of pharmacokinetics of Quercitrin in plasma,Assessment of pharmacokinetics of Quercitrin in plasma,Assessment of pharmacokinetics of Quercitrin in plasma,Assessment of pharmacokinetics of Quercitrin in urine,Assessment of pharmacokinetics of Quercitrin in urine,Assessment of pharmacokinetics of Quercitrin in urine
Summary
The study is a Phase I, randomized double-blind, placebo-controlled, single and multiple
 dosing, dose-escalation study of the oral administration of DDN-A-0101 in healthy adults and
 elderly subjects
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06367426
Non-Device Trial